On the 42nd day of T-DM1 therapy, she exhibited hypocalcemia (serum calcium 7.0 mg/dL) and a decrease in serum HER2 protein levels (from 790 to 428 ng/mL). This evidence concerns the gene ERBB2 and Hypocalcemia.